Pharma Journalist -

Bristol-Myers Squibb Company and Catalent, Inc. announced that Catalent has agreed to purchase Bristol-Myers Squibb’s oral solid, biologics, and sterile product manufacturing and…
Read More...

Ultragenyx Pharmaceutical, Inc. and Arcturus Therapeutics Holdings Inc. announced that they have expanded their collaboration to discover and develop mRNA, DNA and siRNA therapeutics…
Read More...

SMi reports: Hear government perspectives from the Department for International Trade at the Wearable Injectors and Connected Devices Conference this October. The Wearable Injectors…
Read More...

Cognizant announced it has agreed to acquire Zenith Technologies, a privately-held life sciences manufacturing technology services company headquartered in Cork, Ireland. Zenith…
Read More...

Ironwood Pharmaceuticals, Inc. and Allergan plc announced positive topline data from a Phase IIIb clinical trial evaluating LINZESS (linaclotide) 290 mcg on multiple abdominal symptoms…
Read More...

ThermoGenesis Corp., a wholly owned subsidiary of Cesca Therapeutics and a market leader in automated cellular processing, today announced that it has received Health Canada approval of…
Read More...

Premier Inc. and Pensiamo Inc. have partnered to launch a new pharmaceutical supply chain solution that was co-developed with UPMC, a world-renowned healthcare provider and insurer.…
Read More...

Sanofi and Google will establish a new virtual Innovation Lab with the ambition to radically transform how future medicines and health services are delivered by tapping into the power…
Read More...

Roche announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved Rozlytrek (entrectinib) for the treatment of adult and paediatric patients with neurotrophic…
Read More...

Voyager Therapeutics announced a restructuring of its gene therapy relationship with Sanofi Genzyme. Under the terms of the agreement, Voyager gains worldwide rights to the VY-HTT01…
Read More...